Amneal Pharmaceuticals Inc Class A (AMRX)
Cost of Revenue
$461.69M
Quarterly · Period ending: · USD
AMRX Cost of Revenue
Latest reported$461.69Mperiod ending
Latest reported$461.69Mperiod ending
AMRX Quarterly Cost of Revenue ($121.93M → $461.69M)
Quarterly cost of revenue
High-resolution chart · PNG
AMRX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 461,689,000 | |
| 402,406,000 | |
| 517,129,000 | |
| 510,539,000 | |
| 438,255,000 | |
| 439,529,000 | |
| 467,645,000 | |
| 432,910,000 | |
| 451,833,000 | |
| 421,131,000 | |
| 391,500,000 | |
| 387,509,000 | |
| 379,025,000 | |
| 379,354,000 | |
| 394,371,000 | |
| 351,327,000 | |
| 358,836,000 | |
| 323,062,000 | |
| 370,494,000 | |
| 330,082,000 | |
| 322,577,000 | |
| 301,543,000 | |
| 342,962,000 | |
| 385,709,000 | |
| 320,425,000 | |
| 315,034,000 | |
| 287,094,000 | |
| 323,849,000 | |
| 299,393,000 | |
| 363,040,000 | |
| 304,120,000 | |
| 276,382,000 | |
| 235,492,000 | |
| 130,594,000 | |
| 141,953,000 | |
| 119,720,000 | |
| 136,138,000 | |
| 115,832,000 | |
| 121,926,000 |